Diabo, Mary A.

HRN: 06-70-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/22/2025
05/29/2025
IVTT
1.5g
Q8H
Infected Wound
Waiting Final Action 
05/22/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/22/2025
05/29/2025
IVTT
600mg
Q6H
INFECTED WOUND
Waiting Final Action 
05/26/2025
MUPIROCIN 2%, 15G (TUBE)
05/26/2025
06/02/2025
INTRADERM
Apply To Affected Area
BID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: